Brief: Pharmena Plans Pre-Clinical Test Of 1-MNA Drug On Animal Models

Pharmena SA

10/04/2019 09:43

April 10 (Reuters) - Pharmena SA  PHR.WA :
    * VIA ITS US-BASED UNIT CORTRIA CORPORATION PLANS TO LAUNCH
PRE-CLINICAL TEST OF 1-MNA DRUG ON ANIMAL MODELS IN THE NASH
INDICATION
    * PURPOSE OF PRE-CLINICAL TEST TO DETERMINE EFFECTIVE DOSAGE
OF
1-MNA FOR FUTURE CLINICAL TESTS OF IIB PHASE
    * CO ESTIMATES TO PRESENT RESULTS FROM RESEARCH ON ANIMAL
MODELS
WITHIN ABOUT 6 MONTHS

Source text for Eikon:  ID:nEM8wmQH6a 
Further company coverage:  PHR.WA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))